Search hospitals > New Jersey > Englewood
Englewood Hospital and Medical Center
Claim this profileEnglewood, New Jersey 07631
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Atrial Fibrillation
Conducts research for Coronary Artery Disease
Conducts research for Colorectal Cancer
149 reported clinical trials
12 medical researchers
Summary
Englewood Hospital and Medical Center is a medical facility located in Englewood, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Atrial Fibrillation, Coronary Artery Disease, Colorectal Cancer and other specialties. Englewood Hospital and Medical Center is involved with conducting 149 clinical trials across 218 conditions. There are 12 research doctors associated with this hospital, such as Steven Elias, MD, Jill Morrison, MD, Minaxi Jhawer, and David M. Dubin.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Steven Elias, MDEnglewood Hospital and Medical Center3 years of reported clinical research
Studies Venous Insufficiency
Studies Varicose Ulcer
6 reported clinical trials
9 drugs studied
Jill Morrison, MDEnglewood Hospital and Medical Center1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
19 drugs studied
Minaxi JhawerEnglewood Hospital and Medical Center4 years of reported clinical research
Studies Colorectal Cancer
Studies Tumors
4 reported clinical trials
11 drugs studied
David M. DubinEnglewood Hospital and Medical Center8 years of reported clinical research
Studies Breast Cancer
Studies Small Cell Lung Cancer
3 reported clinical trials
8 drugs studied
Clinical Trials running at Englewood Hospital and Medical Center
Breast Cancer
Diffuse Large B-Cell Lymphoma
Bladder Cancer
Pancreatic Cancer
Colorectal Cancer
Lymphoma
Tumors
Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Cancer
Ribociclib Combination Therapy
for Breast Cancer
This is an open-label, multi-center, roll-over study to evaluate the long term safety of ribociclib in combination with other drugs in participants who are participating in a Novartis sponsored global study, that has fulfilled requirements for its primary objective(s), and who in the opinion of the Investigator, would benefit from continued treatment.
Recruiting3 awards Phase 43 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Englewood Hospital and Medical Center?
Englewood Hospital and Medical Center is a medical facility located in Englewood, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Atrial Fibrillation, Coronary Artery Disease, Colorectal Cancer and other specialties. Englewood Hospital and Medical Center is involved with conducting 149 clinical trials across 218 conditions. There are 12 research doctors associated with this hospital, such as Steven Elias, MD, Jill Morrison, MD, Minaxi Jhawer, and David M. Dubin.